Following cancer, cells in a particular tissue can no longer respond to the factors involved in
controlling cell survival, differentiation, proliferation, and death. In recent years, it has been …

The purpose of the American Cancer Society/American Society of Clinical Oncology Breast
Cancer Survivorship Care Guideline is to provide recommendations to assist primary care …

PURPOSE About one third of patients with hormone receptor–positive, human epidermal
growth factor receptor 2–negative breast cancer who have residual invasive disease after …

Background The administration of endocrine therapy for 5 years substantially reduces
recurrence rates during and after treatment in women with early-stage, estrogen-receptor …

Background Recent data suggest that human epidermal growth factor receptor 2 (HER2)-
low breast cancer may represent a distinct entity. We aimed to compare disease …

Background Women treated for breast cancer (BC) often suffer genitourinary syndrome of
menopause. These symptoms may be alleviated by vaginal estrogen therapy (VET) or …

Long-term survival rates after a diagnosis of breast cancer are steadily rising. This is good
news, but clinicians must also recognize that this brings new challenges to the medical …

Background. Oral antineoplastic therapies not only improve survival but also reduce the
burden of care for patients. Yet patients and clinicians face new challenges in managing …

Tumors that express detectable levels of the product of the ESR1 gene (estrogen receptor-α;
ERα) represent the single largest molecular subtype of breast cancer. More women …

Importance Musculoskeletal symptoms are the most common adverse effects of aromatase
inhibitors and often result in therapy discontinuation. Small studies suggest that acupuncture …